Used AviClear for Sale: Current Listings, Used Price Range and What to Check

A used AviClear is listed at $59,000 on the one priced listing we found as of November 2026, a 2023 unit listed by a US dealer as like new and clinic maintained.

One asking price from one seller is not a market range, so we don't publish a used price range or median for AviClear yet.

A second AviClear on the same marketplace is listed without a price, and a higher figure that circulates in search results comes from a listing that has since been taken down.

Set a price alert above to see new listings as they arrive, since every added asking price makes the range more reliable.

AviClear has 3 FDA 510(k) clearances: K213461 (March 24, 2022), K230660 (June 6, 2023) and K251149 (July 11, 2025).

The business model changed more than the hardware: Cutera launched AviClear in North America in 2022 on leases and moved to direct sales in the fourth quarter of 2023.

That history matters more than the model year when you compare used units, because it decides who owns the device.

AviClear is an infrared indium phosphide (InP) diode laser that delivers a nominal 1726 nm wavelength to target sebum in the sebaceous glands.

Ask the seller for the console's voltage and crated weight before you book freight.

AviClear is grouped with used vascular and vein lasers, although it is an acne laser and not a vascular one.

Cutera's 2025 Chapter 11 liquidation analysis says AviClear needs a proprietary "digital consumable" to keep operating.

Cutera books AviClear treatment fees as consumable revenue, so each treatment has a cost paid to Cutera on top of the device price.

At launch in 2022, Cutera's own advertisement set a $5,000 startup investment for the annual license plus a per-patient fee of 50% of the clinic's patient charge or $1,500, whichever was higher.

Those were 2022 lease terms, Cutera changed the model in the fourth quarter of 2023, and we found no current published per-treatment price.

Get Cutera's current per-treatment fee in writing before you buy, and compare it with what AviClear's peers cost per treatment in consumables.

Cutera reported $10.5 million of AviClear treatment revenue in 2023, against $5.4 million in license fees, which shows how much of the cost sat in per-treatment charges.

Check five things on a used AviClear: title, treatment access, the 510(k) on the label, service records and serial match.

1. Title: Cutera placed early units on three-year leases with one-year auto-renewal, so get proof that the seller owns the unit and that any lease was bought out.
2. Treatment access: AviClear runs on a digital consumable, so confirm with Cutera that it will enable treatments for you as the new owner.
3. 510(k) on the label: match the label to K213461, K230660 or K251149.
4. Service records: ask for every service visit and software update, since Cutera assigns the device a useful life of 7 years.
5. Serial match: make sure the serial on the console matches the bill of sale and the records Cutera holds.

AviClear is FDA-cleared for the long-term treatment of mild to severe inflammatory acne vulgaris, the indication in its July 2025 510(k), K251149.

Cutera markets it as the first FDA-cleared energy device for mild to severe inflammatory acne.

That single indication makes AviClear a dedicated acne system, not a multi-use platform.

Cutera does not publish a transfer or recertification fee on its AviClear page, and we found no Cutera policy page that names one.

For AviClear the fee question also covers treatment access, so ask Cutera in writing what it charges to register the unit and to enable treatments for a new owner.

Cutera filed pre-packaged Chapter 11 cases on March 5, 2025 to cut its debt by nearly $400 million, with the aim of emerging as a private company owned by its lenders and employees.

Its March 2025 customer FAQ said the process had no impact on product availability, service or support.

AviClear is still on Cutera's US product menu as of November 2026.

No, not everyone can buy a used AviClear: federal rules let prescription devices be sold only to, or on the order of, a licensed practitioner.

States add their own rules, and Georgia, for example, defines lasers as prescription devices that can be sold only to licensed practitioners with prescriptive authority.

The Cutera excel V and the Candela Vbeam Perfecta from the same category, and the Aerolase Neo from Nd:YAG lasers, are listed at $19,900–$55,000, $25,000–$30,000 and $28,975–$49,000 as of November 2026.

None of the three carries AviClear's acne indication, so compare them on what your clinic treats, not on price alone.

The excel V has the most listings of the three at 7, and its fee and specs are on the excel V's used price, specs and Cutera transfer fee.

The Vbeam Perfecta range covers 6 listings and the Aerolase Neo range covers 3.